Abstract
Hyaluronic acid (HA) is a non-sulphated glycosaminoglycan. It is a natural polymer characterised by a coiled linear chain in particularly well-hydrated configuration composed of repeating disaccaride units. In mammals, its molecular weight can be extremely wide, ranging from 20 to 4,000 kDa. High molecular mass forms are provided with anti-inflammatory properties. A unique characteristic of HA is hydration (up to 6,000 molecules water/molecule of HA) with a major role in the regulation of fluid balance in the interstitium, a fundamental activity on the amorphous colloidal matrix gluing connective cell and fibers, and many other biological functions including lubrication, solute transport and microcirculatory exchange. HA has been widely used in the treatment of eye, ear, joint and skin disorders; in the last 15 years HA has been also proposed successfully in the treatment of a number of lung diseases in vitro, experimental animals and humans. In particular, inhaled HA at relatively high molecular weight has been proven to prevent bronchoconstiction induced in asthmatics by direct and indirect challenges such as inhalation of methacholine, inhalation of ultrasonically nebulised distilled water, muscular exercise. More recently, in patrients affected by chronic obstructive pulmonary diseases, we have demonstrated that repeated administrations of inhaled HA (daily, for 8 weaks) induce significant increase in bronchial patency as well as progressive lung deflation with decrease of residual volume. In conclusion there are elements that can let us state that is perhaps time to change the focus to connective tissue and extracellular matrix substances such as HA, in order to prevent and treat chronic lung diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed T, Abraham WM, D’Brot J (1992) Effects of inhaled heparin on immunologic and non-immunologic bronchoconstriction responses in sheep. Am Rev Respir Dis 145:566–570
Ahmed T, Garrigo J, Danta I (1993) Preventing bronchoconsriction in exercise-induced asthma with inhaled heparin. N Engl J Med 329:90–95
Ahmed T, Gonzales BJ, Danta I (1999) Prevention of exercise-induced bronchoconstriction by inhaled low molecular weight heparin. Am J Respir Crit Care Med 160:576–581
Ahmed T, Hallmon J, Abraham WM (1991) The effect of heparin on immunologically-induced tracheal smooth muscle contraction in allergic sheep. Am Rev Respir Dis 143(Suppl):A360, abstract
Ahmed T, Syriste T, Mendelssohn R, Sorace D, Mansour E, Lansing M, Abraham WM, Robinson MJ (1994) Heparin prevents antigen-induced airway hyperresponsiveness: interference with !P3-mediated mast cell degranulation? J Appl Physiol 76:893–901
Allegra L, Abraham WM, Fasano V, Petrigni G (2008) Methacholine challenge in asthmatics is protected by aerosolised hyaluronan at high (1,000 kDa) but not low (300 kDa) molecular weight. Ital J Chest Dis 62:297–301
Allegra L, Bianco S, Petrigni G, Robuschi M (1974) Lo sforzo muscolare e la nebulizzazione ultrasonica di H2O come test di provocazione aspecifica del broncospasmo. In: Pasargiklian M, Bocca E (eds) Progressi in Medicina Respiratoria. Terme di Sirmione, Sirmione, pp 81–86
Allegra L, Bianco S (1980) Non-specific bronchoreactivity obtained with an ultrasonic aerosol of distilled water. Eur J Respir Dis 61(Suppl 106):41–49
Allegra L, Dal Negro R (1993) Physical agents in bronchial provocation tests: nebulised hypoosmolar aerosol. In: Allegra L, Braga PC, Dal Negro R (eds) Methods in asthmology. Springer, Berlin, pp 219–225
Allegra L, Della Patrona S, Comi A, Fasano V, Longo L, Terzano C, Petrigni G (2006) Aerosols of hyaluronan partially prevent bronchoconstriction induced by ultrasonically nebulised distilled water in asthmatics. Ital J Chest Dis 60:243–248
American Thoracic Society (2000) Guidelines for methacholine and exercise challenge testing 1999. Am J Respir Crit Care Med 161:309–329
Anderson SD (1985) Bronchial challenge by ultrasonically nebulized aerosols. Clin Rev Allergy 3:427–439
Anderson SD, Brannan JD (2004) Methods for “indirect” challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Paediatr Drugs 6:161–175
Anderson SD, Schoeffel RE, Finney M (1983) Evaluation of ultrasonic distilled water for provocation testing in patients with asthma. Thorax 38:284–291
Anderson SD, Schoeffel RE, Follet R, Perry CP, Daviskas E, Kendall M (1982) Sensitivity to heat and water loss at rest and during exercise in asthmatic patients. Eur J Respir Dis 63:459–471
Baccarani-Contri M, Vincenzi D, Cicchetti F, Mori G, Pasquali-Ronchetti I (1990) Immunocytochemical localization of proteoglycans within normal elastin fibers. Eur J Cell Biol 53:305–312
Balasz A, Laurent TC, Jeanlo RW (1986) Nomenclature of hyaluronic acid. Biochem J 235:903, abstract
Bert JL, Pierce RH (1984) The interstitium and microvascular exchange. In: Renkin EM (ed) Handbook of physiology. Section 2: the cardiovascular system, Vol. IV, Pt 1: Microcirculation. American Physiological Society, Bethesda, pp 521–547
Bhattacharya J, Cruz T, Bhattacharya S, Bray BA (1989) Hyaluronan affects extravascular water in lungs of unanesthetized rabbits. J Appl Physiol 66:2595–2599
Blackwood RA, Cantor JO, Moret J, Mandl I, Turino GM (1983) Glycosaminoglycan synthesis in endotoxin-induced lung injury. Proc Soc Exp Biol Med 174:343–349
Bothner H, Wyk O (1987) Rheology of hyaluronate. Acta Otorinolaryngol 442(suppl):25–30
Braya PC, Allegra L. (1988) Methods in Bronchial Mucology, Raven Press, New York
Brown RA, Allegra L, Matera MG, Page CP, Cazzola M (2006) Additional clinical benefits of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulm Pharmacol Ther 19:419–424
Bush A (2008) How early do airway inflammation and remodelling occur? Allergol Int 57:11–19
Cade JF, Pain MCF (1972) Lung function in provoked asthma: response to inhaled urea, methacholine and isoprenaline. Clin Sci 43:759–769
Cantor JO, Cerreta JM, Keller S, Turino GM (1995) Modulation of airspace enlargement in elastase-induced emphysema by intratracheal instillment of hyaluronidase and hyaluronic acid. Exp Lung Res 21:423–436
Cheney FW jr, Butler J (1968) The effect of ultrasonically produced aerosols on airway resistance in man. Anesthesiology 29:1099–1106
Cheney FW jr, Butler J (1970) The effects of ultrasonica aerosols on the total respiratory resistance in the intubated patient. Anesthesiology 32:456–458
Cleland RL, Wang JL (1970) Tonic polysaccharides. III: dilute solution properties of hyaluronic acid fraction. Biopolymers 9:799–810
Dahl R (2008) Glycosaminoglycans: therapeutic opportunities for hyaluronan in respiratory diseases. Ital J Chest Dis 62:289–296
Daviskas E, Anderson SD (2006) Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med 19:100–109
Dentener MA, Vernooy JH, Hendriks S et al (2005) Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 60:114–119
Elwood RK, Hogg JC, Pare PD (1982) Airway response to osmolar challenge in asthma. Am Rev Respir Dis 61(Suppl):125, abstract
Eschenbacher WL, Boushey HA, Sheppard D (1984) Alteration in osmolarità of inhaled aerosols cause bronchoconstriction and cough, but of a permanent anion causes cough alone. Am Rev Respir Dis 129:211–215
Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, function and turnover. J Intern Med 242:27–33
Fraser JRE, Kimpton WG, Laurent TC, Cahill RN, Vakakis N (1988) Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 256:153–158
Fryer A, Huang YC, Rao G, Jacobi D, Mancilla E, Whorton R et al (1997) Selective O- desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J Pharmacol Exp Ther 282:208–219
Garrigo J, Danta I, Ahmed T (1996) Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am J Respir Crit Care Med 153:1702–1707
Goh LT (1998) Effect of colture conditions on rates of intrinsic hyaluronic acid production by Streptococcus equi spp Zooepidermicus. Biotechnol Lett 16:507–512
Goldberg EP, Burns JW, Jacobi Y (1993) Prevention of postoperative adhesion to precoating tissues with diluted sodium hyaluronate solutions. Prog Clin Biol Res 381:191–204
Granger HJ, Laine GA, Barnes JE, Lewis RE (1984) Dynamics and control of transmicrovascular fluid exchange. In: Staub NC et al (eds) Edema. Raven, New York, pp 198–228
Granger HJ (1981) Physicochemical properties of the extracellular matrix. In: Hargens AR (ed) Tissues fluid pressure and composition. Williams & Wilkins, Baltimore, pp 43–61
Hallgren R, Eklund A, Engstrom-Laurent A et al (1985) Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J 290:1778–1781
Haynes BF, Hua-Xin L, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347–350
Hogg JC, Eggleston PA (1984) Is asthma an epithelial disease? Am Rev Respir Dis 129:207–208
Itano N, Sawai T, Yoshida M et al (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085–25092
Johnson PR, Roth M, Tamm M et al (2001) Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 164:474–477
Keity CM, Whittaker SP, Grant MF, Shuttleworth CA (1992) Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J Cell Biol 118:979–990
King SR, Hickerson WL, Proctor KG (1991) Beneficial actions of exogenous hyaluronic acid on wound healing. Surgery 109:76–84
Klagas I, Goulet S, Karakiulakis G, Zhong J, Baraket M, Black JL, Papakonstantinou E, Royh M (2009) Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J 34:616–628
Kunz LIZ, van Rengen ELJ, Sterk PJ (2006) Inhaled hyaluronic acid against exercise-induced broncho-constriction in asthma. Pulm Pharmacol Ther 19:286–291
Laurent TC (1970) Structure of hyaluronic acid. In: Balasz EA (ed) Chemistry and molecular biology of the intercellular matrix. Academic, London, pp 703–732
Laurent UGB, Reed RK (1991) Turnover of hyaluronan in the tissue. Adv Drug Deliv Rev 7:237–256
Lever R, Page C (2001) Glycosaminoglycans, airways inflammation and bronchial inflammation. Pulm Pharmacol Ther 14:249–254
Magyar P, Dervaderics M, Tòth A, Lantos A (1983) Inhalation of hypertonic potassium chloride solution: a specific bronchial challenge for asthma. Ital J Chest Dis 37:29–34
Marchette LC, Marchette BE, Abraham WM, Wanner A (1985) The effect of systemic hydration on normal and impaired mucociliary function. Pediatr Pulmonol 1:107–111
McFadden ER, Lenner KAM, Strohl KP (1986) Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. J Clin Invest 78:18–25
Meyer K, Palmer JW (1934) The polysaccharide in vitreous humour. J Biol Chem 107:629–634
Monzon ME, Casalino-Matsuda SM, Forteza RM (2006) Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 34:135–141
Papakonstantinou E, Karakiulakis G, Eickelberg O et al (1998) A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology 8:821–830
Petrigni G, Allegra L (2006) Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharmacol Ther 19:166–171
Poole AR, Dieppe P (1994) Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 23:17–31
Postma DS, Timens W (2006) Remodelling in asthma and chronic obstructive pulmonary disease. Proc Am Thor Soc 3:434–439
Potter PC, Klein M, Weinberg EG (1991) Hydration in severe acute asthma. Arch Dis Child 66:216–299
Reed RK, Bowen BD, Bert JL (1989) Microvascular exchange and interstitial volume regulation in the rat: implication of the model. Am J Physiol 257H:2081–2091
Reed RK, Laurent UGB (1992) Turnover of hyaluronan in the microcirculation. Am Rev Respir Dis 146:S37–S39
Schmid K, Grundboeck-Jusco J, Kimura A, Tschopp FA, Zollinger R, Binette JP, Lewis W, Hayashi S (1982) The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging. Biochem Biophys Acta 716:178–187
Schoeffel RE, Anderson SD, Altounyan RE (1981) Bronchial hyperreactity in response to inhalation of ultrasonically nebulized solutions of distilled water and saline. Br Med J 283:1285–1287
Scuri M, Abraham WM, Botvinnikova Y, Forteza R (2001) Hyaluronic acid blocks porcine pancreatic elastase (PPE)-induced broncho-constriction in sheep. Am J Crit Care Med 164:1855–1859
Scuri M, Abraham WM (2003) Hyaluronan blocks human neutrophil elastase (HNE)-induced air way responses in sheep. Pulm Pharmacol Ther 16:335–340
Scuri M, Sabater J, Abraham WM (2007) Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep. J Appl Physiol 102:2324–2331
Shaw RJ, Anderson SD, Durham SR, Taylor KM, Schoeffel RE, Green W, Torzillo P, Kay AB (1985) Mediators of hypersensitivity and “fog”-induced asthma. Allergy 40:48–57
Sheppard D, Rtzk N, Boushey HA (1983) Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis 127:691–694
Sheppard D, Eschenbacher WL (1984) Respiratory water loss as a stimulus to exercise-induced bronchoconstriction. J Allergy Clin Immunol 73:640–642
Singleton R, Moel DI, Cohn RA (1986) Preliminary observation of impaired water excretion in treated status asthmaticus. Am J Dis Child 140:59–61
Smedrson B, Perthof H, Gustavson S, Laurent TC (1990) Scavenger function of the liver endothelial cell. Biochem J 266:313–327
Toole BP (1990) Hyaluronan and its binding proteins, hyaladerins. Curr Opin Cell Biol 2:839–844
Toole BP (1991) Glycosaminoglycans and morphogenesis. In: Hay ED (ed) Cell biology and extracellular M2trix. Plenum, New York, pp 259–294
Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–539
Tranfa CM, Vatrella A, Parrella R, Pelaia G, Bariffi F, Marsico S (2001) Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics. Eur J Clin Pharmacol 57:59
Turino GM (1986) The pulmonary parenchyma: a dynamic matrix (J. Burns Amberson lecture). Am Rev Respir Dis 132:1324–1334
Turino GM (2003) Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med 167:1169–1175
Underhill CB (1992) CD44: the hyaluronan receptor. J Cell Sci 103:193–198
Valerio G, Salerno FG, Bracciale P (2007) The i.v. infusion of mannitol decreases air way responsiveness to methacholine in asthma. Respir Physiol Neurobiol 156:374–377
Venge P, Pedersen B, Hakansson L, Hallgren R, Lindblad G, Dahl R (1996) Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med 153:312–316
Vitanzo PC jr, Sennett BJ (2006) Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop 35:421–428
Yang B, Zhang L, Turley EA (1993) Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 268:8617–8623
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Allegra, L., Patrona, S.D., Petrigni, G. (2012). Hyaluronic Acid. In: Lever, R., Mulloy, B., Page, C. (eds) Heparin - A Century of Progress. Handbook of Experimental Pharmacology, vol 207. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-23056-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-23056-1_17
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-23055-4
Online ISBN: 978-3-642-23056-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)